Related Experiment Video
Updated: Jul 14, 2025

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Tolfenpyrad displays Francisella-targeted antibiotic activity that requires an oxidative stress response regulator
Ashley Clarke1, Isabelle M Llabona1, Nimra Khalid1
1Department of Infectious Diseases & Immunology, University of Florida , Gainesville, Florida, USA.
Importance:
Francisella species are highly pathogenic bacteria that pose a threat to global health security. These bacteria can be made resistant to antibiotics through facile methods, and we lack a safe and protective vaccine. Given their history of development as bioweapons, new treatment options must be developed to bolster public health preparedness. Here, we report that tolfenpyrad, a pesticide that is currently in use worldwide, effectively inhibits the growth of Francisella. This drug has an extensive history of use and a plethora of safety and toxicity data, making it a good candidate for development as an antibiotic. We identified mutations in Francisella novicida that confer resistance to tolfenpyrad and characterized a transcriptional regulator that is required for sensitivity to both tolfenpyrad and reactive oxygen species.
Insights
Tolfenpyrad, a pesticide, effectively inhibits pathogenic Francisella growth. Researchers identified Francisella novicida mutations conferring resistance and a regulator affecting sensitivity to tolfenpyrad and reactive oxygen species.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Francisella species are highly pathogenic bacteria posing a global health security threat.
- Existing antibiotics are insufficient, and no protective vaccine is available against Francisella.
- The potential for Francisella to be developed as bioweapons necessitates novel treatment strategies.
Purpose of the Study:
- To identify potential new therapeutic agents against Francisella infections.
- To investigate the efficacy of the pesticide tolfenpyrad as an antimicrobial treatment.
- To understand the mechanisms of resistance and sensitivity to tolfenpyrad in Francisella.
Main Methods:
- Screening of existing drugs for activity against Francisella.
- Antimicrobial susceptibility testing of Francisella with tolfenpyrad.
- Genetic analysis to identify mutations conferring resistance to tolfenpyrad in Francisella novicida.
- Characterization of transcriptional regulators involved in Francisella novicida sensitivity.
Main Results:
- Tolfenpyrad demonstrated significant inhibition of Francisella growth.
- Specific mutations in Francisella novicida were identified that confer resistance to tolfenpyrad.
- A transcriptional regulator essential for sensitivity to both tolfenpyrad and reactive oxygen species was characterized.
Conclusions:
- Tolfenpyrad is a promising candidate for development as a novel antibiotic against Francisella due to its established safety profile.
- Understanding resistance mechanisms is crucial for the effective clinical application of tolfenpyrad.
- The identified transcriptional regulator provides insights into Francisella's response to oxidative stress and potential drug treatments.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Stringent Response in E. coli
Other Stress Responses in Bacteria
Development of Antibiotic Resistance

